BJDX - CIK 0001704287
The table below shows Bluejay Diagnostics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.68M | $3.08M | $4.44M | $3.12M | $5.76M | $8.06M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.97M |
| $3.35M |
| $4.75M |
| $3.57M |
| $6.57M |
| $9.02M |
| Property, plant & equipment | $1.53M | $1.39M | $1.48M | $1.50M | $1.53M | $1.55M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $5.60M | $4.89M | $6.40M | $5.28M | $8.35M | $10.86M |
| Accounts payable | $220.29K | $161.16K | $108.82K | $519.52K | $316.65K | $490.06K |
| Total current liabilities | $1.41M | $1.15M | $1.04M | $1.32M | $1.05M | $2.06M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.42M | $1.20M | $1.11M | $1.41M | $1.19M | $2.22M |
| Retained earnings | -$43.44M | -$40.09M | -$38.49M | -$36.53M | -$33.24M | -$31.75M |
| Total equity | $4.18M | $3.69M | $5.29M | $3.87M | $7.16M | $8.64M |